Showing results (101-110 of 123) with videos related to

Sort By:
Pageof 13
Undersea & Hyperbaric Medicine : Journal of the Undersea and Hyperbaric Medical Society, Inc|February 3, 2005
Regional CBF in chronic stable TBI treated with hyperbaric oxygenK F Barrett, B Masel, J Patterson, et al.
Kidney International|September 28, 2007
Renal inter-alpha-trypsin inhibitor heavy chain 3 increases in calcium oxalate stone-forming patientsA P Evan, S Bledsoe, E M Worcester, et al.
American Journal of Obstetrics and Gynecology|June 1, 1996
Phase II study of high-dose cisplatin, etoposide, and cyclophosphamide for refractory ovarian cancerJ M Cain, C Collins, S Petersdorf, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 16, 2000
Phase I study of paclitaxel, carboplatin, and increasing days of prolonged oral etoposide in ovarian, peritoneal, and tubal carcinoma: a gynecologic oncology group studyP G Rose, M Rodriguez, S Waggoner, et al.
Journal of Biomolecular Structure & Dynamics|March 19, 2025
Prediction and assessment of energetically-favored binding orientation of cannabidiol at hNav1.1 channel using all-atom molecular dynamics simulationsKrishna Chaturvedi, Kyle S Bledsoe, Pankaj Pandey, et al.
International Journal of Radiation Oncology, Biology, Physics|November 15, 1993
Femoral vessel depth and the implications for groin node radiationW J Koh, M Chiu, K J Stelzer, et al.
Gynecologic Oncology|October 20, 1999
Pretreatment scalene node biopsy in gynecologic malignancy: prudent or passé?N S Horowitz, H K Tamimi, B A Goff, et al.
American Journal of Obstetrics and Gynecology|June 1, 1994
Paclitaxel (Taxol) treatment for refractory ovarian cancer: phase II clinical trialV L Seewaldt, B E Greer, J M Cain, et al.
Pageof 13